UF study finds alterations in early visual perceptual processing in people with OCD.
NIH grant supports conference to consider routine monitoring of smell and taste throughout life as part of health care.
Fifth annual ReMission Summit brought together top brain tumor researchers and clinicians to advance new treatments.
Scientists at The Wertheim UF Scripps Institute report that a common amino acid can deliver a “slow-down” signal to the brain, likely influencing major depression, anxiety and other mood disorders in some people.
Catch up on some of the latest neuroscience and neuromedicine research news around the MBI and beyond.
Dr. Michalina Janiszewska, Ph.D., a cancer biologist at The Herbert Wertheim UF Scripps Institute, offers insight into glioblastoma mechanisms.
To celebrate Brain Awareness Week, UF neuroscience students brought interactive demonstrations to K-12 students.
SKYCLARYS was tested and approved by the FDA to treat Friedrich’s ataxia.
Tara Hearns to serve as chief operating officer, overseeing day-to-day operations at the Norman Fixel Institute.
Jaffee is the founding director of UF’s Brain Injury, Rehabilitation and Neuroresilience Center and is board certified in neurology, psychiatry, sleep medicine and brain injury medicine with additional certifications in behavioral neurology and neuropsychiatry.